Results 61 to 70 of about 517,918 (229)

Blood glucose and lactate levels as early predictive markers in patients presenting with cardiogenic shock: A retrospective cohort study.

open access: yesPLoS ONE
Lactate and glucose are widely used biochemical parameters in current predictive risk scores for cardiogenic shock. Data regarding the relationship between lactate and glucose levels in cardiogenic shock are limited. Thus, we aimed to analyze glucose and
Hannah Billig   +8 more
doaj   +1 more source

Pheochromocytoma in a Postpartum Patient With Cardiogenic Shock From Epicardial Vasospasm Necessitating Mechanical Circulatory Support

open access: yesAnnals of Internal Medicine: Clinical Cases
A 25-year-old woman presented with pheochromocytoma crisis and cardiogenic shock. Her ejection fraction was severely reduced at 10%, and she needed venoarterial extracorporeal membrane oxygenation (VA-ECMO) for hemodynamic support.
Justin Brilliant   +4 more
doaj   +1 more source

Association between Public Reporting of Outcomes and the Use of Mechanical Circulatory Support in Patients with Cardiogenic Shock

open access: yesJournal of Interventional Cardiology, 2019
Risk-averse behavior has been reported among physicians and facilities treating cardiogenic shock in states with public reporting. Our objective was to evaluate if public reporting leads to a lower use of mechanical circulatory support in cardiogenic ...
Vikas Singh   +7 more
doaj   +1 more source

Mechanical circulatory support in cardiogenic shock

open access: yesJournal of Intensive Care, 2023
Cardiogenic shock is a complex and diverse pathological condition characterized by reduced myocardial contractility. The goal of treatment of cardiogenic shock is to improve abnormal hemodynamics and maintain adequate tissue perfusion in organs.
Jun Nakata   +5 more
doaj   +1 more source

The Surgeon\u27s Role in Cardiogenic Shock.

open access: yes, 2021
PURPOSE OF REVIEW: Cardiogenic shock represents a very challenging patient population due to the undifferentiated pathologies presenting as cardiogenic shock, difficult decision-making, prognostication, and ever-expanding support options.
Williams, Matthew   +7 more
core  

Prevalence of transthyretin cardiac amyloidosis in undifferentiated heart failure with preserved ejection fraction

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1176-1182, April 2025.
Abstract Aims Transthyretin amyloid cardiomyopathy (ATTR‐CM) is an increasinglyrecognized cause of heart failure with preserved ejection fraction (HFpEF), which may be diagnosed non‐invasively using 99mTc 3,3‐diphosphono‐1,2‐propanodicarboxylic acid (DPD) scintigraphy‐based diagnostic criteria.
L. Healy   +15 more
wiley   +1 more source

Percutaneous ventricular assist devices for cardiogenic shock

open access: yes, 2008
Cardiogenic shock complicates up to 7% of ST-segment elevation myocardial infarctions and 2.5% of non-ST-segment elevation myocardial infarctions, with an associated mortality of 50% to 70%.
Windecker, Stephan, Cook, Stéphane
core  

Stress induced cardiomyopathy complicated by cardiogenic shock: A non-survivor case

open access: yesEgyptian Journal of Critical Care Medicine, 2018
Stress induced cardiomyopathy complicated by refractory cardiogenic shock is challenging as treatment by inotropes and vasopressors may be ineffective.
M. Abouelwafa   +8 more
doaj   +1 more source

Association of BMI with adherence and outcome in heart failure patients treated with wearable cardioverter defibrillator

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1295-1303, April 2025.
Abstract Background Obesity is a known risk factor for cardiovascular disease (CVD), yet an ‘obesity paradox’ has been observed in various CVD contexts. The impact of obesity on heart failure (HF) patients treated with a wearable cardioverter‐defibrillator (WCD) remains underexplored.
Mohammad Abumayyaleh   +18 more
wiley   +1 more source

Post Myocardial Infarction Cardiogenic Shock

open access: yes, 2011
Cardiogenic shock is often a devastating consequence of acute myocardial infarction (MI) and portends to significant mortality and morbidity. Despite improvements in expediting the time to treatment and enhancements in available medical therapy and ...
Yerem Yeghiazarians, Ramford Ng
core   +1 more source

Home - About - Disclaimer - Privacy